BioPharm International - March2020

BioPharm International - Regulatory

Issue link: https://www.e-digitaleditions.com/i/1224576

Contents of this Issue

Navigation

Page 1 of 51

Strong beginnings have never been more important. Help ensure clinical success. © 2019 Cygnus Technologies. All rights reserved. With you all the way. cygnustechnologies.com Cygnus has pioneered advanced orthogonal methods and impurity analysis solu ons you can trust to accelerate your bioprocess development into scale-up for produc on. For over 25 years, we have helped the biopharmaceu cal industry by providing value-added analy cs for host cell proteins and other bioprocess-related impuri es. From process development to product lot release: • ensure regulatory compliance early • help pa ent safety and improve clinical outcomes • reduce the me to market Orthogonal HCP Analysis Bioprocess Impurity ELISA Host Cell Protein ELISA Kits Custom HCP assay development Assay qualifica on

Articles in this issue

Links on this page

Archives of this issue

view archives of BioPharm International - March2020 - BioPharm International - Regulatory